Dopamine or norepinephrine for low blood pressure in very preterm babies
Treatments studied
Part of Genetic & congenital, Infections clinical trials.
This trial compares two common medicines—dopamine versus norepinephrine—to treat low blood pressure in very preterm babies who have suspected or confirmed late-onset bloodstream infection (sepsis). It may help doctors find which medicine works better and more safely for this specific situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born very early (32 weeks or less gestational age)
- Your baby is more than 48 hours old
- Your baby is currently getting a first-choice “blood pressure support” medicine (dopamine or norepinephrine)
- Low blood pressure is happening along with suspected or confirmed late-onset sepsis or necrotizing enterocolitis
- There are no known chromosome or genetic problems
- The main blood-pressure medicine is dopamine or norepinephrine (not another first-choice drug)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the right amount of a blood pressure medicine (vasopressor) for newborns and infants under 2 years old during surgery. It aims to find a safe and effective dose to support their blood pressure during anesthesia.
This trial tests if the oral medication midodrine can help wean patients with sepsis off IV vasopressors faster, potentially reducing ICU stays and complications.
This trial compares two medicines (dopamine and norepinephrine) to see which works better for raising blood pressure in newborns who have both low blood pressure and high blood pressure in the lungs. Both medicines are given through a vein to help stabilize your baby's blood pressure.
This trial tests whether giving a medicine called norepinephrine early and adjusting the dose quickly can help people with sepsis who have very low blood pressure. It is for adults who are diagnosed within the last 3 hours and who have not already received this medicine.
This Phase 3 trial tests whether starting a medicine called norepinephrine early can improve outcomes for adults with sepsis (a serious body-wide response to infection) and low blood pressure. You might be considered if you’re very early in hospital care and meet specific blood pressure and lactate tests.
This trial tests whether starting norepinephrine early can improve outcomes for adults with sepsis who have low blood pressure. It may help stabilize circulation sooner and reduce complications from severe infection.
Hear when a new Extreme Prematurity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.